China's Changing Reimbursement Landscape Reshapes Pharma Market
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's prescription drugs market has seen a slowdown in growth in large cities due to implementation of government pilot reimbursement projects that could be adopted nationwide, according to a Sept. 27 Citi report